Mercury and Movement Disorders: The Toxic Legacy Continues.

Autoimmune movement disorder Cerebellar ataxia Mercury Myoclonus Parkinsonism Tremor

Journal

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
ISSN: 0317-1671
Titre abrégé: Can J Neurol Sci
Pays: England
ID NLM: 0415227

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 5 8 2021
medline: 2 7 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

Mercury (Hg) exists in the environment as inorganic (metallic Hg vapor, mercurous and mercuric salts) or organic (bonded to a structure containing carbon atoms) forms. Neurotoxic effect of Hg is known for years. While the organic form (methylmercury (meHg)) led to the Minamata incidence in Japan and "wonder-wheat" disaster in Iraq, the "mad hatters" and "Danbury shakes" were related to the inorganic elemental form (Hg vapor). Human exposure to toxic Hg continues in the modern world to a large extent by artisanal gold mining, biomass combustion, chloralkali production, and indigenous medicine use to name a few. Heavy industrial use of Hg contaminates air and landfills, affecting the aquatic ecosystem and marine food chain. A detailed social and occupational history with a high index of clinical suspicion is required to not miss this toxic etiology for movement disorders like ataxia, tremor, or myoclonus. In this review, we have discussed the past and present global health impact of Hg from a movement disorder perspective. The connection of Hg with neurodegeneration and autoimmunity has been highlighted. We have also discussed the role of chelating agents and the preventive strategies to combat the neurotoxic effects of Hg in the modern world.

Identifiants

pubmed: 34346303
pii: S0317167121001463
doi: 10.1017/cjn.2021.146
doi:

Substances chimiques

Methylmercury Compounds 0
Mercury FXS1BY2PGL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-501

Auteurs

Jacky Ganguly (J)

London Movement Disorder Centre, London Health Sciences Centre, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada, N6A 5A5.

Dinkar Kulshreshtha (D)

London Movement Disorder Centre, London Health Sciences Centre, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada, N6A 5A5.

Mandar Jog (M)

London Movement Disorder Centre, London Health Sciences Centre, University of Western Ontario, 339 Windermere Road, London, Ontario, Canada, N6A 5A5.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH